杏吧原创

Engimmune Therapeutics logo

Engimmune Therapeutics

Startups icon 杏吧原创 Score 33 Startups icon Startups

1

Founding Rounds

2

Investors

$15.8m

Money raised

Overview

  • Website:
  • Business model: b2b
  • Company size: 1 - 11 employees
  • Headquarters: Basel, Switzerland
  • Founded: 2021
  • Social accounts:

Investors (2)

Novo A/S logo Novo A/S

Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, ...

Details
Pureos Bioventures logo Pureos Bioventures

Health Tech, Hardware, Biotech, Pharma, Manufacturing, ...

Details

View all investors.

Sign up

Join 23,000+ founders, operators and investors.

Fonding

Fonding series

Funding Series Analysis

The company Engimmune Therapeutics has raised a total of $15.8m in funding over 1 rounds.

Key Insights:

  • Seed: $15.8m
Engimmune Therapeutics logo
Engimmune Therapeutics Seed (2022, $15M) $15.8m